Aerosol delivery to children

Pediatric Annals

Volumn 35, Issue 9, 2006, Pages 630-636

  Everard, Mark L ^a  

^a SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID DERIVATIVE;

AEROSOL; ASTHMA; BRONCHIECTASIS; COGNITION; CYSTIC FIBROSIS; DRUG DELIVERY SYSTEM; DRUG DOSE REGIMEN; DRUG FATALITY; HUMAN; METERED DOSE INHALER; PATIENT ATTITUDE; PATIENT COMPLIANCE; PNEUMONIA; REVIEW; TACHYCARDIA; TREATMENT PLANNING; TREMOR; UNSPECIFIED SIDE EFFECT;

EID: 33748994806     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/0090-4481-20060901-06     Document Type: Review

References (34)

1. Sakula A. A history of asthma. The FitzPatrick lecture 1987. J R Coll Physicians Lond. 1988;22(1):36-44.
2. O'Callaghan C, Nerbrink O, Vidgren M. The history of inhaled drugs. In: Bisgaard H, O'Callaghan C, Smaldone G, eds. Lung Biology in Health and Disease. New York, NY: Marcel Dekker; 2001.
3. Speizer FE, Doll R, Heaf P. Observations on recent increase in mortality from asthma. Brit Med J. 1968;1(5588):335-339.
4. Pearce N, Beasley R, Crane J, Burgess C, Jackson R. End of the New Zealand asthma mortality epidemic. Lancet. 1995;345(8941):41-44.
5. Brown HM, Storey G, George WH. Beclomethasone diproprionate: a new steroid aerosol for the treatment of allergic asthma. Brit Med J. 1972;1(800):585-590.
6. Friegang B. New method of beclomethasone aerosol administration to children under 4 years of age. Can Med Assoc J. 1977;117(11):1308-1309.
7. Everard ML. CFC transition: the emperor's new clothes. Each class of drug deserves a delivery system that meets its own requirements. Thorax. 2000;55(10):811-814.
8. Quattrin T, Belanger A, Bohannon NJ, Schwartz SL, Exubera Phase III Study Group. Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial. Diabetes Care. 2004;27(11):2622-2627.
9. Cramer JA, Okikawa J, Bellaire S, Clauson P. Compliance with inhaled insulin treatment using the AERx iDMS Insulin Diabetes Management System. Diabetes Technol Ther. 2004;6(6):800-807.
10. Webb J, Rees J, Clark TJ. A comparison of the effects of different methods of administration of beta-2-sympathomimetics in patients with asthma. Br J Dis Chest. 1982;76(4):351-357.
11. Patel L, Wales JK, Kibirige MS, et al. Symptomatic adrenal insufficiency during inhaled corticosteroid treatment. Arch Dis Child. 2001;85(4):330-334.
12. Dunlop KA, Carson DJ, Steen HJ, et al. Monitoring growth in asthmatic children treated with high dose inhaled glucocorticoids does not predict adrenal suppression. Arch Dis Child. 2004;89(8):713-716.
13. Everard ML, Le Souef PN. Aerosol therapy and delivery systems. In: Textbook of Paediatric Respiratory Medicine. Taussig L, Landau L, eds. St. Louis: Mosby; 1998.
14. Brennan VK, Osman LM, Graham H, Critchlow A, Everard ML. True device compliance: the need to consider both competence and contrivance. Respir Med. 2005;99(1):97-102.
15. Paterson IC, Crompton GK. Use of pressurised aerosols by asthmatic patients. Brit Med J. 1976;1(6001):76-77.
16. Giraud V, Roche N. 2002. Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. Eur Respir J. 19:246-251.
17. Janssens HM, Devadason SG, Hop WC, et al. Eur Respir J. 1999;13(4):787-791.
18. Everard ML. Inhaler devices in infants and children: challenges and solutions. J Aerosol Med. 2004;17(2):186-195.
19. Murakami G, Igarashi T, Adachi Y, et al. Measurement of bronchial hyperreactivity in infants and preschool children using a new method. Ann Allergy. 1990;64:383-387.
20. Schuepp KG, Devadson S, Roller C, Wildhaber JH. A complementary combination of delivery device and drug formulation for inhalation therapy in preschool children. Swiss Med Wkly. 2004;134(13-14):198-200.
21. Wildhaber JH, Dore ND, Wilson JM, Devadason SG, LeSouef PN. Inhalation therapy in asthma: nebulizer or pressurized metered-dose inhaler with holding chamber? In vivo comparison of lung deposition in children. J Pediatr. 1999;135(1):28-33.
22. van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, et al. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group. Am Rev Respir Dis. 1992;146(3):547-554.
23. Calpin C, MacArthur C, Stephens D, et al. Effectiveness of prophylactic inhaled steroids in childhood asthma: a systematic review of the literature. J Allergy Clin Immunol. 1997;100(4):452-457.
24. Marchant JM, Masters IB, Taylor SM, et al. Evaluation and outcome of young children with chronic cough. Chest. 2006;129(5):1132-1141.
25. Everard ML. Regimen and device compliance: key factors in therapeutic outcomes. J Aerosol Med. 2006;19(1):67-73.
26. Osman LM, Hyland ME. Adherence and self management. In: Gibson P, Abramson M, Costabel U, et al., eds. Evidence-based Respiratory Medicine. London: BMJ Books; 2004: 91-105.
27. Gibson NA, Ferguson AE, Aitchison TC, Paton JY. Compliance with inhaled asthma medication in preschool children. Thorax. 1995;50(12):1274-1279.
28. Braunstein GL, Trinquet G, Harper AE. Compliance with nedocromil sodium and a nedocromil sodium/salbutamol combination. Eur Respir J. 1996;9(5):893-898.
29. Bultman DC, Svarstad BL. Effects of physician communication style on client medication beliefs and adherence with antidepressant treatment. Patient Educ Couns. 2000;40(2):173-185.
30. Kesten S, Zive K, Chapman KR. Pharmacist knowledge and ability to use inhaled medication delivery systems Chest. 1993;104(6):1737-1742.
31. Hanania N, Wittman R, Kesten S, Chapman R. Medical personnel's knowledge of and ability to use inhaling devices. Metered-dose inhalers, spacer chambers, and breath-actuated dry powder inhalers. Chest. 1994;105(1):111-116.
32. Tsang KW, Lam WK, Ip M, et al. Inability of physicians to use metereddose inhalers. J Asthma. 1997;34(6):493-498.
33. Kamps AWA, van Ewijk B, Roorda RJ, Brand PL. Poor inhalation technique, even after inhalation instructions, in children with asthma. Pediatr Pulmonol. 2000;29(1):39-42.
34. Devadason SG, Everard ML, MacEarlan C, Roller C, Summers QA, Swift P, Borgstrom L, Le Souef PN. Lung deposition from the Turbuhaler in children with cystic fibrosis. Eur Respir J. 1997;10(9):2023-2028.